Latest News – PSNC Main site Pharmaceutical Services Negotiating Committee

  • July 2017 Price Concessions/NCSO (further update)
    Posted by Mitesh on 21st July 2017 at 3:54 pm

    The Department of Health has granted the following price concessions for July 2017: Drug Pack size Price concession Betahistine 16mg tablets 84 £11.95 Betahistine 8mg tablets 84 £5.85 Buspirone 10mg tablets 30 £9.57 Dapsone 50mg tablets 28 £46.19 Diamorphine 30mg powder for solution for injection ampoules 5 £16.52 Exemestane 25mg tablets (new) 30 £65.00 […]

  • Hosting a pharmacy visit for your local MP (July 2017)
    Posted on 21st July 2017 at 3:16 pm

    This PSNC Briefing provides guidance to help LPCs to organise successful visits to community pharmacies for local Members of Parliament. PSNC Briefing 048/17: Hosting a pharmacy visit for your local MP If you have any queries on this PSNC Briefing or you require more information, please contact Zoe Long, Head of Communications and Public Affairs. To browse... […]

  • Consultation on items which should not be routinely prescribed in primary care
    Posted by buxtona on 21st July 2017 at 2:58 pm

    NHS Clinical Commissioners (NHSCC) and NHS England have today published proposals on 18 medicines which they suggest should no longer be routinely prescribed  in primary care, because they are either: clinically ineffective, unsafe or not cost effective; or the NHS can offer a clinically-proven alternative for patients. The proposals have been developed by an expert... […]

  • LPC News: Study shows variation in LA commissioning of public health services
    Posted by taylorr on 21st July 2017 at 2:18 pm

    BMJ Open has published the results of a study which evaluated variation in local authority (LA) commissioning of community pharmacy public health services in England in 2014/15. Information for the study was gathered via freedom of information requests to LA commissioners, as well as using data from the PSNC Services Database and PharmOutcomes. A total... […]

  • Health & Care Review
    Posted by alkharsanz on 21st July 2017 at 1:32 pm

    Keeping up with all the latest developments in health and care policy could almost be a full time job and PSNC regularly receives questions from LPCs and pharmacy contractors about what is going on in the wider health and care landscape beyond community pharmacy. To help answer some of these questions and to help contractors and... […]

  • EPS enhancements survey – pharmacy teams, please share your views
    Posted by ahthiond on 19th July 2017 at 8:36 am

    NHS Digital has launched a survey to gather the views of community pharmacy teams about which enhancements to the Electronic Prescription Service (EPS) they would like to see prioritised. This survey was prepared by NHS Digital with support from PSNC and the RPS. All pharmacy staff can now take part in this work by completing... […]

  • July 2017 Price Concessions/NCSO (update)
    Posted by Mitesh on 18th July 2017 at 3:55 pm

    The Department of Health has granted the following price concessions for July 2017: Drug Pack size Price concession Betahistine 16mg tablets 84 £11.95 Betahistine 8mg tablets 84 £5.85 Buspirone 10mg tablets 30 £9.57 Dapsone 50mg tablets 28 £46.19 Diamorphine 30mg powder for solution for injection ampoules 5 £16.52 Mefenamic acid 500mg tablets 28 £55.00 […]

  • Contractor Announcement: August Category M Adjustments
    Posted by mabbuttm on 18th July 2017 at 2:58 pm

    Category M reimbursement prices will be reduced from August by £15m per month for a 12-month period. The reductions correct overpayments of retained margin for both 2015/16 and 2016/17. Both Department of Health (DH) and PSNC margins analysis, which are based on data from the independent sector, identify substantial excess margin for the two periods.... […]

  • Service case study: The community pharmacy patient activation project in Cornwall
    Posted by alkharsanz on 18th July 2017 at 8:30 am

    In December 2016, Cornwall & Isles of Scilly LPC and the South West Cardiovascular Clinical Network, with support from Pfizer, launched a developmental service in 20 community pharmacies across Cornwall to benefit patients with type 2 diabetes. What is the aim of the service? The aim of the service is to increase patients’ Patient Activation... […]

  • Quality Payments – How to become a Healthy Living Pharmacy Level 1 (July 2017)
    Posted by mabbuttm on 17th July 2017 at 3:48 pm

    This PSNC Briefing provides an overview of how to achieve the Healthy Living Pharmacy (HLP) criterion of the Quality Payments (QP) Scheme for the November 2017 review point. PSNC Briefing 003/17 and 016/17, published in January 2017 and March 2017 respectively, provided an overview of how to achieve the ‘HLP Level 1’ quality criterion of... […]